dc.creator | Vega Blanco, María Margarita | |
dc.creator | Devoto, Luigi | |
dc.creator | Castro, Olga | |
dc.creator | Kohen Skop, Paulina | |
dc.date.accessioned | 2019-01-29T14:53:05Z | |
dc.date.available | 2019-01-29T14:53:05Z | |
dc.date.created | 2019-01-29T14:53:05Z | |
dc.date.issued | 1994 | |
dc.identifier | Journal of Clinical Endocrinology and Metabolism, Volumen 79, Issue 2, 2018, Pages 466-469 | |
dc.identifier | 0021972X | |
dc.identifier | 10.1210/jc.79.2.466 | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/161192 | |
dc.description.abstract | To assess the role of estradiol (E2) upon progesterone (P4) synthesis, a well defined human midluteal cell system was used. A dose-dependent inhibition of P4 synthesis with and without hCG was induced by E2. In addition, E2 had a dose related cumulative effect on pregnenolone as compared with control experiments (2-fold, P < 0.05) as well as in hCG- stimulated conditions (3-fold, P < 0.005). On the other hand, the concentrations of 20α-hydroxyprogesterone obtained in all experimental conditions were similar to control values, indicating that the catabolism of P4 was not modified. 3β-Hydroxysteroid dehydrogenase activity was significantly diminished (P < 0.05) in the presence of E2. Finally, the kinetic studies on P4 synthesis from pregnenolone showed a competitive type of inhibition with a K1 of 2.22 x 10-6 mol/L. These data indicate an inhibition of 3β-hydroxysteroid dehydrogenase on human corpus luteum by E2. | |
dc.language | en | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
dc.source | Journal of Clinical Endocrinology and Metabolism | |
dc.subject | Endocrinology, Diabetes and Metabolism | |
dc.subject | Biochemistry | |
dc.subject | Endocrinology | |
dc.subject | Clinical Biochemistry | |
dc.subject | Biochemistry (medical) | |
dc.title | Progesterone synthesis by human luteal cells: Modulation by estradiol | |
dc.type | Artículo de revista | |